Drug Detail
Information about Keytruda + Cyclophosphamide
Generic Name |
Pembrolizumab + Cyclophosphamide | |
|---|---|---|
IND |
MK-3475 | |
Brand Name (US) |
Keytruda + Cyclophosphamide | |
Manufacturer |
||
Drug Type |
Anti-PD-1 antibody, Chemotherapy | |
Delivery |
Oral + Intravenous | |
Approval Status |
Approved for a non-GIST application | |
Indications |
Melanoma + | |
Overall Strategy |
Immune system | |
Strategy |
Stimulate the immune system, Modulate the anti-inflammatory immune response | |
Drug Category |
Immunotherapeutic | |
Search for this drug/combination in: